A rare case of Mitochondrial Fatty Acid Oxidation Defect- Systemic Primary Carnitine Deficiency

  • Dr Manisha Garg SMS medical college, Jaipur, India
  • Dr Sneha Dhruw SMS medical college, Jaipur, India
  • Dr Dhananjay Kumar Mangal Babylon Hospital, Jaipur, India,
  • Dr Chanchal Singhal Babylon Hospital, Jaipur, India,
  • Dr Khurshida Khan Senior Resident, Department of Paediatrics, SMS Medical College, Jaipur, India
Keywords: Primary carnitine deficiency, Carnitine, Fatty acid oxidation

Abstract

Systemic primary carnitine deficiency (SPCD) also known as, carnitine transporter deficiency (CTD) is an inborn error of fatty acid transport caused by a defect in the transporter responsible for moving carnitine across the plasma membrane, leading to a variety of symptoms such as chronic muscle weakness, cardiomyopathy and hypoglycaemia and liver dysfunction. The first suspicion of SPCD in a patient with a non-specific presentation is an extremely low plasma carnitine level, confirmed by demonstrating reduced carnitine transport in skin fibroblasts from the patient. Treatment for SPCD involves high dose carnitine supplementation, which must be continued for life. We report a case of Systemic primary carnitine deficiency with classical clinical & laboratory characteristics.

Downloads

Download data is not yet available.

References

1. Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet. 2006;142C(2):77-85. [PubMed]

2. Roe C, Ding J. Mitochondrial fatty acid oxidation disorders. In: Scriver C, Beaudet A, Sly W, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 8 McGraw-Hill; New York: 2001. pp. 2297–2326.

3. Shoji Y, Koizumi A, Kayo T, Ohata T, Takahashi T, Harada K, Takada G. Evidence for linkage of human primary systemic carnitine deficiency with D5S436: a novel gene locus on chromosome 5q. Am J Hum Genet. 1998 Jul;63(1):101-8.

4. Waber, L. J., Valle, D., Neill, C., DiMauro, S., Shug, A. Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport. J. Pediat. 101: 700-705, 1982.

5. Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med. 1988 Nov 17;319(20):1331-6. [PubMed]

6. Koizumi A et al., Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum Mol Genet. 1999;8:2247–2254.

7. Wilcken B, Wiley V, Sim KG, Carpenter K. Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J Pediatr. 2001;138:581–584. [PubMed]

8. Bieber LL. Carnitine. Annu Rev Biochem. 1988;57:261–83. [PubMed]

9. Scaglia F, Wang Y, Singh RH, Dembure PP, Pasquali M, Fernhoff PM, Longo N. Defective urinary carnitine transport in heterozygotes for primary carnitine deficiency. Genet Med. 1998;1:34–9.
A rare case of Mitochondrial Fatty Acid Oxidation Defect- Systemic Primary Carnitine Deficiency
CITATION
DOI: 10.17511/ijpr.2016.i11.05
Published: 2016-11-30
How to Cite
Dr Manisha Garg, Dr Sneha Dhruw, Dr Dhananjay Kumar Mangal, Dr Chanchal Singhal, & Dr Khurshida Khan. (2016). A rare case of Mitochondrial Fatty Acid Oxidation Defect- Systemic Primary Carnitine Deficiency. Pediatric Review: International Journal of Pediatric Research, 3(11), 802-804. https://doi.org/10.17511/ijpr.2016.i11.05
Section
Case Report